Washington Robin L
CIK 0001327145 Name as filed on the most recent filing
Filed as Washington Robin L (49)
96 transaction lines · from 49 filings · filed 2007-01-30 to 2025-03-03 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
- ISSUER Salesforce, Inc. 2 filings
- ISSUER Vertiv Holdings Co 1 filings
- ISSUER Gilead Sciences Inc 43 filings
- ISSUER Hyperion Solutions Corp 3 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
96 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2025-02-28 |
Salesforce, Inc. CRM |
P, Open-market purchase | 1,695 acquired | 294.60 | 499,355.48 | Form 4, filing 0001127602-25-007566 | |
| 2024-11-19 |
Vertiv Holdings Co VRT |
S, Open-market sale | 883 disposed | 135.48 | 119,632.99 | Form 4, filing 0001628280-24-048850 | |
| 2024-11-19 |
Vertiv Holdings Co VRT |
S, Open-market sale | 703 disposed | 137.77 | 96,849.99 | Form 4, filing 0001628280-24-048850 | |
| 2024-11-19 |
Vertiv Holdings Co VRT |
S, Open-market sale | 701 disposed | 136.56 | 95,726.32 | Form 4, filing 0001628280-24-048850 | |
| 2024-11-19 |
Vertiv Holdings Co VRT |
S, Open-market sale | 696 disposed | 138.78 | 96,592.55 | Form 4, filing 0001628280-24-048850 | |
| 2024-11-19 |
Vertiv Holdings Co VRT |
S, Open-market sale | 683 disposed | 134.04 | 91,549.05 | Form 4, filing 0001628280-24-048850 | |
| 2024-11-19 |
Vertiv Holdings Co VRT |
S, Open-market sale | 650 disposed | 128.13 | 83,286.97 | Form 4, filing 0001628280-24-048850 | |
| 2024-11-19 |
Vertiv Holdings Co VRT |
S, Open-market sale | 343 disposed | 132.62 | 45,487.84 | Form 4, filing 0001628280-24-048850 | |
| 2024-11-19 |
Vertiv Holdings Co VRT |
S, Open-market sale | 327 disposed | 130.35 | 42,624.94 | Form 4, filing 0001628280-24-048850 | |
| 2024-11-19 |
Vertiv Holdings Co VRT |
S, Open-market sale | 14 disposed | 125.61 | 1,758.54 | Form 4, filing 0001628280-24-048850 | |
| 2019-03-21 |
Salesforce COM Inc CRM |
S, Open-market sale | 4,051 disposed | 164.97 | 668,299.95 | Form 4, filing 0001127602-19-013037 | |
| 2019-03-21 |
Salesforce COM Inc CRM |
S, Open-market sale | 2,503 disposed | 165.65 | 414,626.71 | Form 4, filing 0001127602-19-013037 | |
| 2019-03-21 |
Salesforce COM Inc CRM |
S, Open-market sale | 880 disposed | 166.51 | 146,528.98 | Form 4, filing 0001127602-19-013037 | |
| 2019-03-21 |
Salesforce COM Inc CRM |
S, Open-market sale | 200 disposed | 163.14 | 32,628.00 | Form 4, filing 0001127602-19-013037 | |
| 2018-02-28 |
Gilead Sciences Inc GILD |
S, Open-market sale | 5,000 disposed | 80.31 | 401,566.00 | Form 4, filing 0001127602-18-009770 | |
| 2017-09-07 |
Gilead Sciences Inc GILD |
S, Open-market sale | 33,750 disposed | 85.00 | 2,868,750.00 | Form 4, filing 0001127602-17-027282 | |
| 2017-09-07 |
Gilead Sciences Inc GILD |
S, Open-market sale | 18,070 disposed | 85.00 | 1,535,950.00 | Form 4, filing 0001127602-17-027282 | |
| 2016-02-16 |
Gilead Sciences Inc GILD |
S, Open-market sale | 6,250 disposed | 90.72 | 567,000.00 | Form 4, filing 0001127602-16-042274 | |
| 2015-11-02 |
Gilead Sciences Inc GILD |
S, Open-market sale | 4,350 disposed | 109.61 | 476,805.68 | Form 4, filing 0001179110-15-014473 | |
| 2015-11-02 |
Gilead Sciences Inc GILD |
S, Open-market sale | 1,900 disposed | 109.13 | 207,343.96 | Form 4, filing 0001179110-15-014473 | |
| 2015-09-02 |
Gilead Sciences Inc GILD |
S, Open-market sale | 3,150 disposed | 102.60 | 323,175.51 | Form 4, filing 0001179110-15-013022 | |
| 2015-09-02 |
Gilead Sciences Inc GILD |
S, Open-market sale | 3,000 disposed | 101.75 | 305,261.10 | Form 4, filing 0001179110-15-013022 | |
| 2015-09-02 |
Gilead Sciences Inc GILD |
S, Open-market sale | 100 disposed | 103.41 | 10,341.00 | Form 4, filing 0001179110-15-013022 | |
| 2015-05-01 |
Gilead Sciences Inc GILD |
S, Open-market sale | 5,742 disposed | 105.33 | 604,787.06 | Form 4, filing 0001179110-15-007166 | |
| 2015-05-01 |
Gilead Sciences Inc GILD |
S, Open-market sale | 5,200 disposed | 106.02 | 551,313.88 | Form 4, filing 0001179110-15-007166 | |
| 2015-05-01 |
Gilead Sciences Inc GILD |
S, Open-market sale | 3,700 disposed | 104.23 | 385,642.86 | Form 4, filing 0001179110-15-007166 | |
| 2015-05-01 |
Gilead Sciences Inc GILD |
S, Open-market sale | 2,200 disposed | 103.48 | 227,661.06 | Form 4, filing 0001179110-15-007166 | |
| 2015-02-02 |
Gilead Sciences Inc GILD |
S, Open-market sale | 24,392 disposed | 105.14 | 2,564,523.66 | Form 4, filing 0001179110-15-001899 | |
| 2015-02-02 |
Gilead Sciences Inc GILD |
S, Open-market sale | 8,200 disposed | 105.98 | 869,026.98 | Form 4, filing 0001179110-15-001899 | |
| 2015-02-02 |
Gilead Sciences Inc GILD |
S, Open-market sale | 600 disposed | 106.85 | 64,111.02 | Form 4, filing 0001179110-15-001899 | |
| 2014-11-03 |
Gilead Sciences Inc GILD |
S, Open-market sale | 21,435 disposed | 110.15 | 2,361,056.68 | Form 4, filing 0001179110-14-016210 | |
| 2014-11-03 |
Gilead Sciences Inc GILD |
S, Open-market sale | 7,282 disposed | 109.59 | 798,030.01 | Form 4, filing 0001179110-14-016210 | |
| 2014-11-03 |
Gilead Sciences Inc GILD |
S, Open-market sale | 2,775 disposed | 111.69 | 309,936.14 | Form 4, filing 0001179110-14-016210 | |
| 2014-11-03 |
Gilead Sciences Inc GILD |
S, Open-market sale | 1,700 disposed | 112.24 | 190,813.95 | Form 4, filing 0001179110-14-016210 | |
| 2014-08-25 |
Gilead Sciences Inc GILD |
S, Open-market sale | 4,304 disposed | 105.87 | 455,664.48 | Form 4, filing 0001179110-14-013317 | |
| 2014-08-14 |
Gilead Sciences Inc GILD |
S, Open-market sale | 33,556 disposed | 95.56 | 3,206,611.36 | Form 4, filing 0001179110-14-012977 | |
| 2014-08-01 |
Gilead Sciences Inc GILD |
S, Open-market sale | 22,500 disposed | 91.26 | 2,053,435.50 | Form 4, filing 0001179110-14-012377 | |
| 2014-08-01 |
Gilead Sciences Inc GILD |
S, Open-market sale | 8,100 disposed | 92.09 | 745,912.80 | Form 4, filing 0001179110-14-012377 | |
| 2014-06-30 |
Gilead Sciences Inc GILD |
S, Open-market sale | 10,400 disposed | 83.98 | 873,403.44 | Form 4, filing 0001179110-14-011221 | |
| 2014-06-04 |
Gilead Sciences Inc GILD |
S, Open-market sale | 6,426 disposed | 82.52 | 530,273.52 | Form 4, filing 0001179110-14-009872 | |
| 2014-05-06 |
Gilead Sciences Inc GILD |
S, Open-market sale | 3,000 disposed | 79.91 | 239,730.00 | Form 4, filing 0001179110-14-007988 | |
| 2014-05-01 |
Gilead Sciences Inc GILD |
S, Open-market sale | 11,250 disposed | 79.30 | 892,125.00 | Form 4, filing 0001179110-14-007665 | |
| 2014-05-01 |
Gilead Sciences Inc GILD |
S, Open-market sale | 8,710 disposed | 79.39 | 691,474.71 | Form 4, filing 0001179110-14-007665 | |
| 2014-05-01 |
Gilead Sciences Inc GILD |
S, Open-market sale | 4,800 disposed | 78.76 | 378,048.00 | Form 4, filing 0001179110-14-007665 | |
| 2014-05-01 |
Gilead Sciences Inc GILD |
S, Open-market sale | 2,840 disposed | 78.61 | 223,258.93 | Form 4, filing 0001179110-14-007665 | |
| 2014-02-28 |
Gilead Sciences Inc GILD |
S, Open-market sale | 19,276 disposed | 83.63 | 1,612,009.47 | Form 4, filing 0001179110-14-004422 | |
| 2014-02-28 |
Gilead Sciences Inc GILD |
S, Open-market sale | 8,846 disposed | 84.05 | 743,496.57 | Form 4, filing 0001179110-14-004422 | |
| 2014-02-28 |
Gilead Sciences Inc GILD |
S, Open-market sale | 2,478 disposed | 82.38 | 204,128.97 | Form 4, filing 0001179110-14-004422 | |
| 2014-02-21 |
Gilead Sciences Inc GILD |
S, Open-market sale | 5,000 disposed | 83.24 | 416,217.50 | Form 4, filing 0001179110-14-003582 | |
| 2014-02-19 |
Gilead Sciences Inc GILD |
S, Open-market sale | 968 disposed | 83.36 | 80,692.48 | Form 4, filing 0001179110-14-003319 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- P, Open-market purchase
- Open-market purchase
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 1
- Open-market sale 95
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Washington Robin L, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001327145
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6